112 algorithm-development-"Multiple"-"Prof"-"Prof"-"Simons-Foundation"-"St" positions at City of Hope
Sort by
Refine Your Search
-
, glioblastomas, colon cancer, and lung cancer. Advancing precision oncology through machine-learning models: We integrate multimodal patient data, including multiomic data and health record information, to develop
-
tools to identify novel signaling pathways to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in regulating both normal
-
Scientist will be responsible for the development and execution of major research projects, as well as the supervision and mentorship of junior laboratory staff. They will also be expected to collaborate with
-
Postdoctoral Fellow. This is an excellent opportunity to join a well-established team and lead projects that culminate in publications in high-impact journals. Our research focuses on drug development
-
cultures (e.g., T cell and tumor cell lines). · Develop and adapt new manufacturing procedures and analytical methodology. · Cooperate with Quality Control (QC) and Quality Assurance (QA
-
maker for the development, implementation and evaluation of standards of care, policies, guidelines and the introduction of new equipment and technology at the point of care. Supports nurses in
-
cultures (e.g., T cell and tumor cell lines). · Assist in developing and adapting new manufacturing procedures and analytical methodology. · Cooperate with Quality Control (QC) and Quality
-
within the Department of Population Sciences and Department of Surgery with some guidance from a Ph.D. level Biostatistician. The incumbent will assist in the development of programs and databases using
-
insights and discoveries that contribute to advancing medical knowledge and developing new treatments. Under direct supervision of the Manager, the incumbent is responsible for supporting clinical trials
-
following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis